PCRX Latest Press Releases

-- September 9, 2026 --

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- August 7, 2026 --

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- August 6, 2026 --

Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases Globe Newswire 8:00 AM

-- August 4, 2026 --

Pacira BioSciences Reports Second Quarter 2026 Financial Results Globe Newswire 4:01 PM

-- July 28, 2026 --

Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America's Workforce Globe Newswire 8:00 AM

-- July 27, 2026 --

Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process Globe Newswire 8:00 AM

-- July 22, 2026 --

Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026 Globe Newswire 8:00 AM

-- July 8, 2026 --

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- July 1, 2026 --

Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL Globe Newswire 8:00 AM

-- June 30, 2026 --

Pacira BioSciences Announces Agreement to Divest its iovera Business to Zimmer Biomet Globe Newswire 7:30 AM

-- June 9, 2026 --

Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting PRNewswire 5:54 PM

-- June 4, 2026 --

Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting PRNewswire 4:20 PM

-- June 1, 2026 --

Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees PRNewswire 4:50 PM

-- May 28, 2026 --

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "FOR" All of Pacira's Director Nominees Globe Newswire 4:20 PM

DOMA PERPETUAL CAPITAL MANAGEMENT QUESTIONS WHY SHAREHOLDERS SHOULD VOTE TO CONTINUE WITH A BOARD THAT HAS OVERSEEN A DECADE OF VALUE DESTRUCTION PRNewswire 9:19 AM

-- May 27, 2026 --

Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company's Strategic Direction and Highly Qualified Nominees Globe Newswire 4:20 PM

After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead Globe Newswire 9:00 AM

Pacira BioSciences Reports Real-World Study Showing EXPAREL Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty Globe Newswire 8:00 AM

-- May 26, 2026 --

Pacira BioSciences Sets the Record Straight Regarding DOMA's Misleading Statements About Pacira's Intellectual Property Strategy Globe Newswire 8:00 AM

-- May 22, 2026 --

A Reno Biotech Just Rang the Nasdaq Bell - Here's Why the Whole Regenerative-Medicine Tape Is Worth Watching Globe Newswire 10:09 AM

-- May 21, 2026 --

A LETTER TO PACIRA BIOSCIENCES SHAREHOLDERS FROM DOMA PERPETUAL CAPITAL MANAGEMENT LLC PRNewswire 1:54 PM

-- May 20, 2026 --

DOMA Perpetual Director Nominees Send Letter to Shareholders of Pacira Biosciences PRNewswire 12:28 PM

Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders Globe Newswire 6:30 AM

-- May 13, 2026 --

DOMA Perpetual Issues & Mails Letter to Shareholders of Pacira BioSciences - Along with its Definitive Proxy Statement & WHITE Proxy Card - Urging Shareholders to Vote "FOR" DOMA's Three Highly Qualified, Independent Board Candidates PRNewswire 10:59 AM

Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences Globe Newswire 8:00 AM

-- May 12, 2026 --

Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees Globe Newswire 4:01 PM

-- May 8, 2026 --

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- May 5, 2026 --

Pacira BioSciences Mails Letter to Stockholders Globe Newswire 4:20 PM

-- April 30, 2026 --

Pacira BioSciences Reports First Quarter 2026 Financial Results Globe Newswire 4:01 PM

-- April 28, 2026 --

Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders Globe Newswire 4:20 PM

-- April 27, 2026 --

Real-World Data on EXPAREL Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty Globe Newswire 8:00 AM